Lymphomatoid Keratosis an Epidermotropic Type of Cutaneous Lymphoid Hyperplasia: Clinicopathological, Immunohistochemical, and Molecular Biological Study of 6 Cases

Total Page:16

File Type:pdf, Size:1020Kb

Lymphomatoid Keratosis an Epidermotropic Type of Cutaneous Lymphoid Hyperplasia: Clinicopathological, Immunohistochemical, and Molecular Biological Study of 6 Cases STUDY Lymphomatoid Keratosis An Epidermotropic Type of Cutaneous Lymphoid Hyperplasia: Clinicopathological, Immunohistochemical, and Molecular Biological Study of 6 Cases Eiichi Arai, MD; Michio Shimizu, MD; Tetsuya Tsuchida, MD; Seiichi Izaki, MD; Fumihiro Ogawa, MD; Takanori Hirose, MD Objective: To provide evidence that lymphomatoid kera- immunoglobulin heavy chain gene and T-cell receptor tosis should be categorized as an epidermotropic sub- (TCR)-␤ and TCRγ genes was also investigated by the type of cutaneous lymphoid hyperplasia. polymerase chain reaction method. ϩ Design: Clinicopathological, immunohistochemical, and Results: Immunohistochemically, epidermotropic CD20 molecular biological studies of epidermotropic and der- and/or CD79aϩ cells were present. In the upper dermal mal bandlike infiltrates of lymphocytes without ne- lymphocytic infiltrates, the CD3ϩ/CD79aϩ cell ratio ranged crotic keratinocytes, Civatte bodies, or Max-Joseph spaces from 5:5 to 8:2. The CD4ϩ/CD8ϩ cell ratio was within and solar lentigo or seborrheic keratosis adjacent to the normal limits. Rearrangements of the TCRγ gene were lesion, but with epidermal hyperplastic change (clini- demonstrated in 2 cases and of the TCRβ gene in 1 case. cally scaly plaque) in cases of lymphomatoid keratosis. Conventional histopathologic study as well as immuno- Conclusions: Our results indicate that lymphomatoid histochemical examinations for CD1a, CD3, CD4, CD8, keratosis is a clinically benign keratotic lesion but his- CD20, and CD79a and S100 protein and genotypic ex- tologically malignant, simulating mycosis fungoides. aminations were performed. Immunohistochemical findings showed a reaction pat- tern in all cases, but genotypical examination showed Setting: University departments comprising 2 sections some clonal dermatoses. Therefore, “lymphomatoid” of dermatology and 1 section of pathology. keratosis should be classed as a pseudolymphoma, namely, a subtype of cutaneous lymphoid hyperplasia Main Outcome Measures: Ratio of T to B cells and with epidermotropism. of CD4ϩ to CD8ϩ cells, and the phenotype of epidermo- tropic cells were evaluated. Gene rearrangement of the Arch Dermatol. 2007;143:53-59 HE TERM LYMPHOMATOID is noteworthy that the term pseudolym- keratosis was originally pro- phoma was originally adopted to indicate posed by Kossard1 and was a lesion clinically or histologically simu- thought to be a possible lating malignant lymphoma. Therefore, the variant of benign lichen- term lymphomatoid is considered to be Toid keratosis showing lymphomatoid fea- equivalent to so-called pseudolymphoma. tures. He considered that the case re- Epidermotropism is defined as an affin- ported by Evans et al2 as a unilesional ity of tumor cells for the epidermis. Vari- mycosis fungoides (MF) should be termed ous conditions display lymphocytic infil- lymphomatoid keratosis. Clinically, the case trates with tropism for the epidermis. reported by Evans et al2 was character- Epidermotropism was not included in the glossary of the fifth edition of Histopathol- ized by an asymptomatic scaly plaque, but Author Affiliations: ogy of the Skin by Lever and Schaumburg- Departments of Pathology the histological features were those seen 4 (Drs Arai, Shimizu, Ogawa, and Lever in 1975. However, it appeared in in MF. Therefore, the most important the sixth edition in 1983.5 In this text- Hirose) and Dermatology pathological feature of lymphomatoid (Dr Tsuchida), and Department book, epidermotropism was reportedly re- keratosis is epidermotropism resembling stricted to MF as follows5(p764): of Dermatology, Saitama 3 Medical Center (Dr Izaki), that seen in MF. Namely, the term lym- Saitama Medical University, phomatoid in lymphomatoid keratosis in- Presence of mononuclear cells in the epider- Saitama, Japan. dicates histological simulation of MF. It mis without spongiosis occurring in MF. The (REPRINTED) ARCH DERMATOL/ VOL 143, JAN 2007 WWW.ARCHDERMATOL.COM 53 ©2007 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 cells lie either singly, surrounded by a clear halo, or aggre- mal collection of more than 3 lymphocytes, (2) disproportion- gated as in a Pautrier microabscess. Epidermotropism must be ate distribution of haloed lymphocytes in the epidermis, and differentiated from exocytosis. (3) linear aggregates of haloed lymphocytes at the dermoepi- dermal junction. However, there have been descriptions of epidermot- ropism in other tumors. In 1983, Burg and Braun- Falco6(p386) stated that in histiocytosis X, “An important his- IMMUNOHISTOCHEMICAL ANALYSIS tological feature is epidermotropism of the characteristic cells.” Burkert et al7 used the term pseudo-Pautrier ab- A set of 4-µm-thick tissue sections were prepared from forma- lin-fixed and paraffin-embedded blocks, deparaffinized in xy- scess for Langerhans cell microgranulomas, and Klein et 8 lene, rehydrated, and microwaved for 10 minutes at 30% al used the term epidermotropic nature to describe poro- power in citrate buffer, pH 9.0 (Dako Japan, Kyoto) for anti- carcinoma (malignant poroma). Moreover, Murphy and gen retrieval. Endogenous peroxidase activity was blocked us- Schwarting 9 used the term atypical epidermotropic infil- ing 0.3% hydrogen peroxide in methanol for 5 minutes. Im- trate for benign conditions such as lymphomatoid drug munostaining was carried out after antigen retrieval by eruption. Bayer-Garnar et al10 reported that CD68ϩ his- microwaving in 1 mM EDTA (pH 8.0) 2 times for 5 minutes tiocytes showed epidermotropism in benign lichenoid kera- each time at 900 W. Then the streptavidin-biotin-peroxidase tosis. In other words, all cells tropic for the epidermis have complex method was used for immunostaining with a Ven- so far been included in the concept of epidermotropism. tana OH system immunostainer (Ventana-Biotech, Tucson, Therefore, epidermotropism has been used mostly as Ariz). The primary antibodies against the lymphoid antigens were CD1a (O10; Immunotech, Marseille, France [undi- a descriptor for MF, which is epidermotropism in the nar- luted]), CD3 (PS-1; Novocastra, Newcastle-upon-Tyne, En- row sense. All of the cases we have examined have fallen gland [1:100 dilution]), CD4 (1F6; Novocastra [1:40 dilu- into this category, which shows complete histological simi- tion]), CD8 (C8/144B; Dakopatts, Glostrup, Denmark [1:100 larity to MF. The epidermotropism of MF is a phenom- dilution]), CD20 (L26; Dakopatts [1:100 dilution]), CD68 enon whereby lymphocytes infiltrate into the epider- (PG-M1; Dakopatts [1:200 dilution]), CD79a (JCB117; Da- mis, slippery with perinuclear halo, and do not attack the kopatts [1:100 dilution]), ␬chain (A8B5; Dakopatts [1:100 di- basement membrane or keratinocytes. This phenom- lution]), ␭ chain (C4; Immunotech [1:50 dilution]), and S100 enon occurs in specific conditions caused by long- protein (Dakopatts [1:300 dilution]). Human tonsillar tissue standing chronic inflammation in the skin-associated lym- was used as a normal control. The main features evaluated 11 during immunohistochemical testing were (1) the B to T-cell phoid tissue of the upper dermis. Kazakov et al and ϩ ϩ 12 ratio; (2) the ratio of the CD4 to CD8 cells; (3) the pheno- Massone et al have described epidermotropism in sev- type of epidermotropic cells; and (4) the proliferation of eral of the following conditions: (1) disproportionate epi- CD1a- and/or S100 protein-positive cells in the epidermis and dermotropism (presence of many lymphocytes distrib- dermis. uted irregularly), (2) basilar lymphocytes (presence of linear aggregates of small hyperconvoluted lympho- GENOTYPIC ANALYSIS cytes located at the dermoepidermal junction), (3) large epidermal lymphocytes (intraepidermal lymphocytes For genotypic studies, DNA was extracted from 10-µm-thick larger than those in the dermis), (4) Pautrier microab- paraffin sections by proteinase K (200 µg/mL) digestion. The scesses (presence of intradermal collection of more than supernatant containing DNA was used directly for polymerase 3 lymphocytes), and (5) haloed lymphocytes (presence chain reaction amplification. The polymerase chain reaction was of a perinuclear clear space), all of which may be recog- used to detect rearrangement of the immunoglobulin heavy chain nized as epidermotropism in the narrow sense. (IgH) gene using 3 VH primers (FR1c, FR2a, and FR3a) and 2 13 ␤ Based on these facts, we performed clinicopathologi- JH primers (LJH and VLJH) ; the T-cell receptor (TCR) chain ␤ ϩ ␤ ϩ cal, immunohistochemical, and molecular biological stud- gene using the following 5 primer sets: 1 (V J1), 2 (V J2), ␤ ϩ ␤ ϩ ␤ ϩ 14 ␥ ies of 6 cases of clinically benign scaly plaque and epi- 3 (D1 J1), 4 (D1 J2), and 5 (D2 J2) ; and the TCR chain gene using the following 20 mixed primer sets: mix 1 (V V , dermotropism histologically similar to that in MF. We 2 8 V3,V4,V9,J1.12.1,J1.2,J1.32.3,J1.12.1 in,J1.2 in,J1.32.3 in)andmix2(V5, investigated whether lymphomatoid keratosis should be 15 V10,V11,V12,J1.12.1,J1.2,J1.32.3,J1.12.1 in,J1.2 in,J1.32.3 in). classified as an epidermotropic subtype of cutaneous lym- phoid hyperplasia. RESULTS METHODS CLINICAL FINDINGS CASE SELECTION The clinical data are demonstrated in Table 1. The pa- tients ranged in age from 36 to 78 years, with a mean age A retrospective review of the files of Saitama Medical Univer- of 59 years, and the male-female ratio was 1:1. The size sity Hospital and Saitama Medical Center Hospital, Saitama, Ja- (largest diameter) of the lesions ranged from
Recommended publications
  • Skin Lesions in Diabetic Patients
    Rev Saúde Pública 2005;39(4) 1 www.fsp.usp.br/rsp Skin lesions in diabetic patients N T Foss, D P Polon, M H Takada, M C Foss-Freitas and M C Foss Departamento de Clínica Médica. Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo. Ribeirão Preto, SP, Brasil Keywords Abstract Skin diseases. Dermatomycoses. Diabetes mellitus. Metabolic control. Objective It is yet unknown the relationship between diabetes and determinants or triggering factors of skin lesions in diabetic patients. The purpose of the present study was to investigate the presence of unreported skin lesions in diabetic patients and their relationship with metabolic control of diabetes. Methods A total of 403 diabetic patients, 31% type 1 and 69% type 2, underwent dermatological examination in an outpatient clinic of a university hospital. The endocrine-metabolic evaluation was carried out by an endocrinologist followed by the dermatological evaluation by a dermatologist. The metabolic control of 136 patients was evaluated using glycated hemoglobin. Results High number of dermophytosis (82.6%) followed by different types of skin lesions such as acne and actinic degeneration (66.7%), pyoderma (5%), cutaneous tumors (3%) and necrobiosis lipoidic (1%) were found. Among the most common skin lesions in diabetic patients, confirmed by histopathology, there were seen necrobiosis lipoidic (2 cases, 0.4%), diabetic dermopathy (5 cases, 1.2%) and foot ulcerations (3 cases, 0.7%). Glycated hemoglobin was 7.2% in both type 1 and 2 patients with adequate metabolic control and 11.9% and 12.7% in type 1 and 2 diabetic patients, respectively, with inadequate metabolic controls.
    [Show full text]
  • The Prevalence of Cutaneous Manifestations in Young Patients with Type 1 Diabetes
    Clinical Care/Education/Nutrition/Psychosocial Research ORIGINAL ARTICLE The Prevalence of Cutaneous Manifestations in Young Patients With Type 1 Diabetes 1 2 MILOSˇ D. PAVLOVIC´, MD, PHD SLAANA TODOROVIC´, MD tions, such as neuropathic foot ulcers; 2 4 TATJANA MILENKOVIC´, MD ZORANA ÐAKOVIC´, MD and 4) skin reactions to diabetes treat- 1 1 MIROSLAV DINIC´, MD RADOSˇ D. ZECEVIˇ , MD, PHD ment (1). 1 5 MILAN MISOVIˇ C´, MD RADOJE DODER, MD, PHD 3 To understand the development of DRAGANA DAKOVIC´, DS skin lesions and their relationship to dia- betes complications, a useful approach would be a long-term follow-up of type 1 OBJECTIVE — The aim of the study was to assess the prevalence of cutaneous disorders and diabetic patients and/or surveys of cuta- their relation to disease duration, metabolic control, and microvascular complications in chil- neous disorders in younger type 1 dia- dren and adolescents with type 1 diabetes. betic subjects. Available data suggest that skin dryness and scleroderma-like RESEARCH DESIGN AND METHODS — The presence and frequency of skin mani- festations were examined and compared in 212 unselected type 1 diabetic patients (aged 2–22 changes of the hand represent the most years, diabetes duration 1–15 years) and 196 healthy sex- and age-matched control subjects. common cutaneous manifestations of Logistic regression was used to analyze the relation of cutaneous disorders with diabetes dura- type 1 diabetes seen in up to 49% of the tion, glycemic control, and microvascular complications. patients (3). They are interrelated and also related to diabetes duration. Timing RESULTS — One hundred forty-two (68%) type 1 diabetic patients had at least one cutaneous of appearance of various cutaneous le- disorder vs.
    [Show full text]
  • Topical Treatments for Seborrheic Keratosis: a Systematic Review
    SYSTEMATIC REVIEW AND META-ANALYSIS Topical Treatments for Seborrheic Keratosis: A Systematic Review Ma. Celina Cephyr C. Gonzalez, Veronica Marie E. Ramos and Cynthia P. Ciriaco-Tan Department of Dermatology, College of Medicine and Philippine General Hospital, University of the Philippines Manila ABSTRACT Background. Seborrheic keratosis is a benign skin tumor removed through electrodessication, cryotherapy, or surgery. Alternative options may be beneficial to patients with contraindications to standard treatment, or those who prefer a non-invasive approach. Objectives. To determine the effectiveness and safety of topical medications on seborrheic keratosis in the clearance of lesions, compared to placebo or standard therapy. Methods. Studies involving seborrheic keratosis treated with any topical medication, compared to cryotherapy, electrodessication or placebo were obtained from MEDLINE, HERDIN, and Cochrane electronic databases from 1990 to June 2018. Results. The search strategy yielded sixty articles. Nine publications (two randomized controlled trials, two non- randomized controlled trials, three cohort studies, two case reports) covering twelve medications (hydrogen peroxide, tacalcitol, calcipotriol, maxacalcitol, ammonium lactate, tazarotene, imiquimod, trichloroacetic acid, urea, nitric-zinc oxide, potassium dobesilate, 5-fluorouracil) were identified. The analysis showed that hydrogen peroxide 40% presented the highest level of evidence and was significantly more effective in the clearance of lesions compared to placebo. Conclusion. Most of the treatments reviewed resulted in good to excellent lesion clearance, with a few well- tolerated minor adverse events. Topical therapy is a viable option; however, the level of evidence is low. Standard invasive therapy remains to be the more acceptable modality. Key Words: seborrheic keratosis, topical, systematic review INTRODUCTION Description of the condition Seborrheic keratoses (SK) are very common benign tumors of the hair-bearing skin, typically seen in the elderly population.
    [Show full text]
  • HEALTH-RELATED QUALITY of LIFE in MORPHEA by NATASHA
    HEALTH-RELATED QUALITY OF LIFE IN MORPHEA by NATASHA KLIMAS In collaboration with Angela D. Shedd, M.D., Ira H. Bernstein, Ph.D., and Heidi T. Jacobe, M.D., M.S.C.S. DISSERTATION Presented to the Faculty of the Medical School The University of Texas Southwestern Medical Center In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF MEDICINE WITH DISTINCTION IN RESEARCH The University of Texas Southwestern Medical Center Dallas, TX TABLE OF CONTENTS ABSTRACT …………………………………………… iii INTRODUCTION …………………………………………… iv MATERIALS AND METHODS …………………………………….. v RESULTS ………………….………………………………………… x DISCUSSION …….…………………………………………………………….. xiii KEY MESSAGES………………………………………………………………………….. xvi TABLES AND FIGURES…………………………………………………………………… xvii ACKNOWLEDGEMENTS ………………………………………………………………. xxvi REFERENCES…………………………………………………………………………… xxvii ii ABSTRACT Objective: Little is known about health-related quality of life (HRQOL) of patients with morphea (localized scleroderma). We determined the impact of morphea on HRQOL and clinical and demographic correlates of HRQOL. Methods: Cross sectional survey of Morphea in Adults and Children (MAC) cohort. Results: Morphea impairs HRQOL. Patients were particularly affected with respect to emotional well-being and concerns that the disease will progress to their internal organs. Patients with morphea had worse skin-specific HRQOL than those with other skin diseases, including non-melanoma skin cancer, vitiligo, and alopecia (lowest P <.0001). The morphea population was found to have significantly worse global HRQOL scores than the general U.S. population for all subscales (all P ≤.004) with the exception of bodily pain. Comorbidity (r =.35-.51, P ≤ .0029 -.0001) and symptoms of pruritus (r =.38 -.64, P ≤.001-.0001) and pain (r =.46-.74, P <.0001) were associated with impairment in multiple domains of skin-specific and global HRQOL.
    [Show full text]
  • A Case of Focal Acral Hyperkeratosis
    Ann Dermatol Vol. 21, No. 4, 2009 CASE REPORT A Case of Focal Acral Hyperkeratosis Eun Ah Lee, M.D., Hei Sung Kim, M.D., Hyung Ok Kim, M.D., Young Min Park, M.D. Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Focal acral hyperkeratosis (FAH) is a rare genodermatosis the two; FAH does not have elastorrhexis. There has been with an autosomal dominant pattern of inheritance; how- only one previous report of FAH in a Korean patient; a ever, it may also be sporadic. FAH is characterized by 23-year-old female with a non-specific family history of late-onset crateriform keratotic papules, some coalescing in- FAH has been previously described3. We herein report a to plaques, along the borders of the hands and feet. We here- typical case of FAH in a 47-year-old Korean male with an in report a case of FAH in a 47-year-old male with a family autosomal dominant pattern of inheritance. history of similar lesions in three generations. The histo- logical findings revealed focal areas of orthohyperkeratosis CASE REPORT over an area of depressed but otherwise normal epidermis. The dermis showed no specific changes, which dis- A 47-year-old male presented with multiple persistent tinguished this case from acrokeratoelastoidosis, which flesh colored papules on the hands that were first noted shows elastorrhexis of clinically similar lesions. (Ann during early adulthood. The number of lesions had gradu- Dermatol 21(4) 426∼428, 2009) ally increased over the years.
    [Show full text]
  • Fundamentals of Dermatology Describing Rashes and Lesions
    Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous,
    [Show full text]
  • Advances in Seborrheic Keratosis
    A CME/CE-Certified Supplement to Original Release Date: December 2018 Advances in Seborrheic Expiration Date: December 31, 2020 Estimated Time To Complete Activity: 1 hour Participants should read the activity information, Keratosis review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on FACULTY the post-test, you will be directed to a Web page that will Joseph F. Fowler Jr, MD Michael S. Kaminer, MD allow you to receive your certificate of credit via e-mail Clinical Professor and Director Associate Clinical Professor of Dermatology or you may print it out at that time. Contact and Occupational Yale Medical School The online post-test and evaluation can be accessed Dermatology New Haven, Connecticut at http://tinyurl.com/SebK2018. University of Louisville School of Adjunct Assistant Professor of Medicine Medicine (Dermatology), Warren Alpert Medical School Inquiries about continuing medical education (CME) Louisville, Kentucky of Brown University accreditation may be directed to the University of Providence, Rhode Island Louisville Office of Continuing Medical Education & Professional Development (CME & PD) at cmepd@ louisville.edu or (502) 852-5329. Designation Statement eborrheic keratosis (SK) has been called keratinizing surface.12 They can develop virtually The University of Louisville School of Medicine the “Rodney Dangerfield of skin lesions”— anywhere except for the palms, soles, and mucous designates this Enduring material for a maximum of 9 1.0 AMA PRA Category 1 Credit(s)™. Physicians should it earns little respect (as a clinical concern) membranes, but are most commonly observed claim only the credit commensurate with the extent of Sbecause of its benignity, commonality, usual on the trunk and face.6,13 The tendency to develop their participation in the activity.
    [Show full text]
  • Cryosurgery Using the Cryopen®
    Cryosurgery using the CryoPen® FAQ CRYOSURGERY What is cryosurgery? Cryosurgery is a procedure that uses extreme cold to destroy tissue. How can my practice benefit from using cryosurgery in my practice? Cryosurgery in the office offers an excellent modality for eliminating referral time while creating an added source of revenue. How can my patients benefit from having cryosurgery in my practice? Patients will appreciate the efficient use of their time and decreased cost of services by avoiding secondary visits to specialists. By keeping the procedure in house, patients will put a greater value on your practice. How is cryosurgery better than other methods of removing skin lesions? Cryosurgery requires no anesthesia and has less scarring than other techniques of skin lesion removal with minimal post-op care. What is the mechanism of cell destruction in cryosurgery? Cell destruction occurs when a cell is rapidly brought down to a very low temperature. When these two criteria are met (varies with cell type), ice crystals form, destroying the cell organelles and protein matrixes. Water then rushes into the surrounding area causing a blister and a disruption of the local blood supply. Cytologic evidence of cell destruction can be seen as soon as two hours after the procedure. What types of lesions are appropriate to freeze? Almost any unwanted skin lesions are appropriate such as warts, moles, actinic keratosis, seborrheic keratosis, keloids, lentigos, dermatofibromas, and hemangiomas to just name a few. In most practices, over 90% of unwanted lesions encountered are amenable to using cryosurgery. What types of lesions are not appropriate to freeze? All Melanomas and Recurrent Basal Cell Carcinomas are contraindicated for cryosurgery.
    [Show full text]
  • Early Diagnosis and Treatment of Discoid Lupus Erythematosus
    J Am Board Fam Med: first published as 10.3122/jabfm.2009.02.080075 on 5 March 2009. Downloaded from BRIEF REPORT Early Diagnosis and Treatment of Discoid Lupus Erythematosus Suresh Panjwani, MD, MSc, FRACGP Discoid lupus erythematosus is a chronic dermatological disease that can lead to scarring, hair loss, and hyperpigmentation changes in skin if it is not treated early and promptly. It has a prolonged course and can have a considerable effect on quality of life. Early recognition and treatment improves the prog- nosis. The diagnosis is usually made by clinical examination. In some cases histopathology may be re- quired to confirm the diagnosis. The histology is that of an inflammatory interface dermatosis. There is insufficient evidence for which treatment is most effective. Because lesions are induced or exacerbated by ultraviolet exposure, photoprotective measures are important. Potent topical steroids and antima- larials are the mainstay of treatment. Some cases of discoid lupus erythematosus can be refractory to standard therapy; in these cases retinoids, thalidomide, and topical tacrolimus offer alternatives, as do immunosuppressives like azathioprine, cyclosporine, mycophenolate mofetil, and methotrexate. (J Am Board Fam Med 2009;22:206–213.) Lupus erythematosus (LE) is thought to be an 5% of patients with discoid lupus may develop autoimmune disease among other connective tissue SLE1 and 25% of patients with SLE may develop diseases like scleroderma, rheumatoid arthritis, typical chronic discoid lesions at some time during copyright.
    [Show full text]
  • What to Expect Following Cryosurgery “Freezing”
    What to Expect Following CryoSurgery “Freezing” What is Cryosurgery? Cryosurgery is a technique for removing skin lesions that primarily involve the surface of the skin, such as warts, seborrheic keratosis, or actinic keratosis. It is a quick method of removing the lesions with minimal scarring. The liquid nitrogen needs to be applied long enough to freeze the affected skin. By freezing the skin, a blister is created underneath the lesion. Ideally, as the new skin forms underneath the blister, the abnormal skin on the roof of the blister peels off. Occasionally if the lesion is very thick (such as a large wart), only the surface is blistered off. The base or residual lesion may need to be frozen at another visit. What to Expect Over the Next Few Weeks? During Treatment – Area being treated will sting, burn and then possibly itch. Immediately After Treatment – Area will be red sore and swollen. Next Day- Blister or blood blister has formed, tenderness starts to subside. Apply a Band-Aid if necessary. 7 Days- Surface is dark red/brown and scab-like. Apply Vaseline or an antibacterial ointment if necessary. 2 to 4 Weeks- The surface starts to peel off. This may be encouraged gently during bathing, when the scab is softened. No makeup should be applied until area is fully healed. How to Take care of the Skin after Cryosurgery A Band-Aid can be used for larger blisters or blisters in areas that are more likely to be traumatized- such as fingers and toes. If the area becomes dry or crusted, an ointment (Vaseline, Aquaphor) can also be applied.
    [Show full text]
  • Treatment Or Removal of Benign Skin Lesions
    Treatment or Removal of Benign Skin Lesions Date of Origin: 10/26/2016 Last Review Date: 03/24/2021 Effective Date: 04/01/2021 Dates Reviewed: 10/2016, 10/2017, 10/2018, 04/2019, 10/2019, 01/2020, 03/2020, 03/2021 Developed By: Medical Necessity Criteria Committee I. Description Individuals may acquire a multitude of benign skin lesions over the course of a lifetime. Most benign skin lesions are diagnosed on the basis of clinical appearance and history. If the diagnosis of a lesion is uncertain, or if a lesion has exhibited unexpected changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated to confirm the diagnosis. The treatment of benign skin lesions consists of destruction or removal by any of a wide variety of techniques. The removal of a skin lesion can range from a simple biopsy, scraping or shaving of the lesion, to a radical excision that may heal on its own, be closed with sutures (stitches) or require reconstructive techniques involving skin grafts or flaps. Laser, cautery or liquid nitrogen may also be used to remove benign skin lesions. When it is uncertain as to whether or not a lesion is cancerous, excision and laboratory (microscopic) examination is usually necessary. II. Criteria: CWQI HCS-0184A Note: **If request is for treatment or removal of warts, medical necessity review is not required** A. Moda Health will cover the treatment and removal of 1 or more of the following benign skin lesions: a. Treatment or removal of actinic keratosis (pre-malignant skin lesions due to sun exposure) is considered medically necessary with 1 or more of the following procedures: i.
    [Show full text]
  • Lumps & Bumps: Approach to Common Dermatologic Neoplasms
    Case-Based Approach to Common Dermatologic Neoplasms Patrick Retterbush, MD, FAAD Mohs Surgery & Dermatologic Oncology Associate Member of the American College of Mohs Surgery Private Practice: Lockman Dermatology January 27th 2018 Disclosure of Relevant Financial Relationships • I do not have any relevant financial relationships, commercial interests, and/or conflicts of interest regarding the content of this presentation. Goals/Objectives • Recognize common benign growths • Recognize common malignant growths • Useful clues & examination for evaluating melanocytic nevi and when to be concerned for melanoma/atypical moles • How to perform a basic skin biopsy and which method/type to choose • Basic treatment/when to refer Key Questions & Physical Examination Findings for a Growth History Physical Examination • How long has the lesion been • Describing a growth present? – flat or raised? • flat – macule (<1cm) or patch (>1cm) – years, months, weeks • raised – papule (<1cm) or plaque (>1cm) – nodule if deep (majority of lesion in • Has it changed? dermis/SQ) – Size – secondary descriptive features • scaly (hyperkeratosis, retention of strateum – Shape corneum) – Color • crusty (dried serum, blood, or pus on surface) • eroded or ulcerated (partial vs. full thickness – Symptoms – pain, bleeding, itch? epidermal loss) – Over what time frame? • color (skin colored, red, pigmented, pearly) • feel (hard or soft, mobile or fixed) • PMH: • size: i.e. 6 x 4mm – prior skin cancers • Look at the rest of the skin/region of skin • SCC/BCCs vs. melanoma
    [Show full text]